What Is a Non-Recourse Advance?

A non-recourse advance is capital extended to a claimant or law firm against a pending judgment, settlement, or monetizable legal claim. The funder's return is contingent entirely on the claim's outcome. If the claim fails or pays less than expected, the funder absorbs the loss. The claimant owes nothing personally, and the funder has no claim against the claimant's home, business, or unrelated assets.

How the Structure Works in Practice

The transaction begins with due diligence on the claim itself, not the claimant's balance sheet. A litigation funding underwriter reviews the complaint, liability theories, damages calculations, insurance coverage, and the defendant's ability to pay. The funder may also assess the law firm's track record in similar matters.

The Advance Mechanics

The funder and claimant execute a funding agreement that assigns a portion of the claim's eventual proceeds. The advance amount is typically 10% to 20% of the funder's estimated net recovery, though this varies by claim maturity and risk profile. A mature commercial dispute with a solvent defendant and clear liability may command a larger advance than a nascent personal injury case with coverage disputes.

The agreement specifies the repayment waterfall. The funder receives its contracted share from the gross or net recovery, depending on the deal structure. Some arrangements use a multiple of the advance, others a percentage of proceeds, and some a hybrid. The key term is the non-recourse feature: the repayment obligation is secured only by the claim itself.

A Concrete Example

Consider a plaintiff in a breach of contract action with $2 million in provable damages against a solvent counterparty. The case is twelve months from likely trial or settlement. A litigation funder offers a $150,000 non-recourse advance against an expected $800,000 net recovery after fees and costs.

The funding agreement provides that the funder receives the first $300,000 from any recovery, or 35% of the net proceeds, whichever is greater. If the case settles for $750,000 net, the funder receives $300,000. If it settles for $400,000 net, the funder still receives $300,000, assuming the contract structure prioritizes the funder's return. If the case loses at trial and the defendant prevails on appeal, the funder receives nothing. The plaintiff keeps the $150,000 advance and owes no deficiency.

Why It Matters to the Firm Owner

For a litigation funding firm, the non-recourse structure is the product. It defines your risk profile, your pricing, and your competitive positioning. The advance is not a loan in the conventional sense, and mischaracterizing it as one creates regulatory and legal exposure.

Portfolio Construction

A non-recourse book requires different underwriting than recourse lending. You are pricing claim risk, not credit risk. The correlation between claims matters: a portfolio heavy in pharmaceutical mass torts faces different systemic risks than one concentrated on single-defendant commercial disputes. Your reserve methodology must reflect claim-specific loss rates, not general default curves.

Regulatory and Ethical Boundaries

State usury laws generally do not apply to non-recourse advances because there is no absolute obligation to repay. However, some jurisdictions scrutinize whether the effective cost exceeds what a court would deem champertous or unconscionable. Your agreements must clearly distinguish the advance from a loan, with no interest accrual, no payment schedule, and no personal guarantee.

For the claimant's law firm, the non-recourse advance can create conflicts. The attorney's duty to advise on settlement timing may diverge from the funder's interest in maximizing recovery. Some funding agreements require the law firm to acknowledge the arrangement and waive any lien priority disputes. Your firm must document these consents carefully.

Where Practitioners Misstructure the Deal

The most costly error is blurring the non-recourse boundary. A funding agreement that requires the claimant to "make reasonable efforts to pursue the claim" is standard. One that imposes personal liability for failing to cooperate, or that secures the advance against the claimant's real property, ceases to be non-recourse and may recharacterize the transaction as a loan under state law.

The Multiple-Advance Trap

Some funders issue successive advances on the same claim without adjusting the recovery waterfall. The claimant may accumulate $300,000 in advances against a claim that ultimately settles for $500,000 net. If each advance carries a separate return multiple, the stacked obligations can consume the entire recovery or exceed it, leaving the claimant with nothing and the funder with a PR and regulatory problem. The proper structure aggregates all advances into a single priority position with a clear aggregate cap.

The Net vs. Gross Ambiguity

Funding agreements sometimes fail to specify whether the funder's percentage applies to gross recovery before attorney fees and costs, or net recovery after them. On a $1 million gross settlement with $400,000 in fees and costs, the difference between 30% of gross and 30% of net is $120,000. Courts have invalidated agreements for this ambiguity, treating them as unenforceable for lack of mutual understanding.

Related Terms

A litigation funding firm should also understand litigation funding, the broader practice of which non-recourse advance is the central instrument. Proof of loss governs the documentation required to establish claim value in insurance disputes. Subrogation describes the insurer's right to stand in the shoes of a compensated claimant, a frequent complicating factor in funded matters. Insurance bad faith can itself become a funded claim when an insurer's refusal to settle creates independent damages. Waiver of subrogation is a contract term that limits an insurer's recovery rights and may affect the claim's net value available for funding.

If you operate a litigation funding firm and need to reach claimants and law firms with capital to deploy, see how ROI Wire builds correspondent programs for litigation funding firms. For more terms in this practice area, return to the Legal & Claims Recovery glossary hub.